Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 271 AL 285

Magnetoencephalography in neuropsychiatry: ready for application?

Williams MA, Sachdev PS.

Curr Opin Psychiatry. 2010 May;23(3):273-7. doi: 10.1097/YCO.0b013e328338621d.

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.

Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort

Sparks DL, Kryscio RJ, Connor DJ, Sabbagh MN, Sparks LM, Lin Y, Liebsack C.

Neurodegener Dis. 2010;7(1-3):183-6. doi: 10.1159/000295660. Epub 2010 Mar 12.

REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease

Robert PH, Mulin E, Malléa P, David R.

CNS Neurosci Ther. 2010 Oct;16(5):263-71. doi: 10.1111/j.1755-5949.2009.00132.x.

Cognition and function in Alzheimer's disease: identifying the transitions from moderate to severe disease

Schwam E, Xu Y.

Dement Geriatr Cogn Disord. 2010;29(4):309-16. doi: 10.1159/000269837. Epub 2010 Apr 16.

Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics

Duce JA, Bush AI.

Prog Neurobiol. 2010 Sep;92(1):1-18. doi: 10.1016/j.pneurobio.2010.04.003. Epub 2010 May 2.

ECT treatment for two cases of dementia-related aggressive behavior

Wu Q, Prentice G, Campbell JJ.

J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):E10-11. doi: 10.1176/jnp.2010.22.2.247.e10.

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ.

J Nucl Med. 2010 Jun;51(6):913-20. doi: 10.2967/jnumed.109.069088.

Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis

Cummings JL, Ferris SH, Farlow MR, Olin JT, Meng X.

Dement Geriatr Cogn Disord. 2010;29(5):406-12. doi: 10.1159/000296073. Epub 2010 May 21.

[Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences]

Nieoullon A.

Psychol Neuropsychiatr Vieil. 2010 Jun;8(2):123-31. doi: 10.1684/pnv.2010.0208.

Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease

Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang R, Schindler R, Schwam E.

Int Psychogeriatr. 2010 Sep;22(6):973-83. doi: 10.1017/S1041610210000888. Epub 2010 Jun 10.

Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use

van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA.

J Alzheimers Dis. 2010;21(2):519-26. doi: 10.3233/JAD-2010-100288.

The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease

Dev H, Agius M, Zaman R.

Psychiatr Danub. 2010 Jun;22(2):367-9.

Case for and against specificity of depression in Alzheimer's disease

Even C, Weintraub D.

Psychiatry Clin Neurosci. 2010 Aug;64(4):358-66. doi: 10.1111/j.1440-1819.2010.02108.x. Epub 2010 Jun 21.

[Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria]

Schmidt R, Baumhackl U, Berek K, Brücke T, Kapeller P, Lechner A, Rainer M, Stögerer EM.

Neuropsychiatr. 2010;24(2):125-31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias